Bionano Announces Closing of up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesGlobeNewsWire • 07/08/24
Bionano Announces up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesGlobeNewsWire • 07/05/24
Scientific Presentations Highlight OGM's Utility for Cancer Research at Joint Annual Meeting for Three Molecular and Cytogenetic AssociationsGlobeNewsWire • 07/02/24
Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing ResearchGlobeNewsWire • 06/20/24
Bionano Laboratories Announces New Category I CPT Code for OGM Use in Hematological Malignancy AnalysisGlobeNewsWire • 06/17/24
Bionano Reports First Quarter 2024 Results and Highlights Recent Business ProgressGlobeNewsWire • 05/08/24
Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome SequencingGlobeNewsWire • 04/11/24
Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesGlobeNewsWire • 04/04/24
Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical CytogeneticsGlobeNewsWire • 04/03/24
Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Including Live Product Showcase Featuring the Company's New Stratys™ SystemGlobeNewsWire • 03/07/24
Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024GlobeNewsWire • 03/05/24
Bionano to Report Fourth Quarter and Year End 2023 Financial Results and Host a Conference Call and Webcast on March 5, 2024GlobeNewsWire • 02/28/24
Bionano Announces Amendment to Debt Financing Arrangement to Extend Cash RunwayGlobeNewsWire • 02/28/24
Bionano to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceGlobeNewsWire • 01/31/24
Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal TestingGlobeNewsWire • 01/24/24
Bionano Announces Full Commercial Release of the Stratys™ System for High Throughput Optical Genome MappingGlobeNewsWire • 01/23/24
Bionano Announces the Final Speaker Lineup for 2024 Symposium with 33 OGM Presentations and Live Panel Discussions Across a Wide Range of Research ApplicationsGlobeNewsWire • 01/19/24